In Treatment for Renal Cell (Kidney) Cancer

For people with advanced clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, researchers are continuing to look for new treatments, especially for cancer that has stopped responding to standard therapies. One potential new option is casdatifan, a treatment designed to block a protein called HIF-2α. Early results from a clinical […]

Learn what to expect during Cabometyx treatment for advanced renal cell carcinoma. Discover tips for managing side effects, diet, and tracking your progress.

Understand clear cell renal cell carcinoma treatment options. Learn about staging, nephrectomy procedures, and how to build a personalized roadmap for care.

At the 2026 ASCO Genitourinary Cancers Symposium, new studies highlighted advances in renal cell (kidney) cancer treatment. There were exciting updates on novel combinations of immunotherapy and targeted therapies that can provide more treatment options for patients. Below are some of the top headlines. A potential new standard option for high-risk patients with clear cell […]

Immunotherapy has transformed treatment for advanced renal cell (kidney) cancer, but for many patients, it can cause significant side effects that sometimes lead to treatment delays or interruptions. New research is exploring whether improving gut health could make these treatments work better and more safely. In a small early-phase clinical trial, researchers tested whether fecal […]

Surgery is a common and important part of treatment for many people with renal cell (kidney) cancer. Whether surgery is done to remove part of the kidney or the entire kidney, it can play a key role in controlling the cancer and supporting long-term outcomes. Because renal cell (kidney) cancer surgery involves the abdomen and […]

Over the past few years, there’s been tremendous progress in how doctors understand and treat renal cell (kidney) cancer. From new insights into the genetics behind the disease to more precise, personalized treatment options, below are some of the advancements you should know about. Understanding the genetics of renal cell (kidney) cancer Renal cell (kidney) […]

In this conversation with Dr. Toni Choueiri, a leading kidney cancer expert at Dana-Farber Cancer Institute, he shares practical guidance on complementary therapies, exercise, and strategies to maintain quality of life. He offers encouragement for patients and families facing a diagnosis, emphasizing the importance of a whole-body approach for navigating treatment and side effects. View […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. Don’t miss this special session with Dr. Toni Choueiri, a leading kidney cancer specialist from Dana-Farber Cancer Institute and Harvard Medical School. Dr. Choueiri shares the […]